Grigorios Siokas Purchases 353,321 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 353,321 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was bought at an average price of $0.50 per share, with a total value of $176,660.50. Following the transaction, the chief executive officer directly owned 8,091,795 shares in the company, valued at $4,045,897.50. The trade was a 4.57% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, January 14th, Grigorios Siokas acquired 493,495 shares of Cosmos Health stock. The stock was purchased at an average price of $0.45 per share, for a total transaction of $222,072.75.
• On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.50 per share, with a total value of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The shares were purchased at an average price of $0.52 per share, with a total value of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.52 per share, for a total transaction of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The stock was purchased at an average price of $0.54 per share, for a total transaction of $72,334.62.
• On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was purchased at an average price of $0.49 per share, with a total value of $43,273.86.
• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were acquired at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.63 per share, for a total transaction of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The shares were acquired at an average price of $0.68 per share, with a total value of $38,134.40.

Cosmos Health Trading Up 4.0%

Shares of COSM traded up $0.02 on Wednesday, reaching $0.52. 1,445,338 shares of the company’s stock were exchanged, compared to its average volume of 1,614,791. The business has a 50 day moving average price of $0.55 and a two-hundred day moving average price of $0.73. Cosmos Health Inc. has a 12 month low of $0.28 and a 12 month high of $1.32. The stock has a market capitalization of $19.28 million, a P/E ratio of -0.69 and a beta of 5.37. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The business had revenue of $17.11 million for the quarter, compared to analyst estimates of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Research analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Cosmos Health presently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC increased its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the quarter. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.